Johnson & Johnson reports clinical trial results for robotic surgery system
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
May 5, 2026 7:00 AM EDTStudy results represent a critical milestone for the investigational OTTAVA Robotic Surgical System
Data demonstrates feasibility of novel system architecture with tableintegrated robotic arms in spaceconstrained ORs
Abstract presented at the 2026 American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting Presidential Grand Round Sessions in San Antonio, Texas
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Today, Johnson & Johnson announced results from the first clinical study of the investigational OTTAVA Robotic Surgical System a prospective, multicenter clinical study evaluating the safety and performance of the... More
